Elsevier Contributes Scopus Data to Development of Russian Map of Science

MOSCOW, October 10, 2013 /PRNewswire/ --

Russian Ministry of Education has signed an agreement to include Scopus Custom Data in the development of a national research assessment tool

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that the Russian Ministry of Education and Science has signed an agreement to include Scopus Custom Data in a nation-wide research assessment tool: Russia's Map of Science.

The project for Russia's Map of Science launched last year as part of governmental initiatives to reform and invest in the country's science and education system. The development of the tool will enable efficient research assessment at the country, institute or individual researcher level. These insights will help determine the current status of Russian research output, predict trends for growth in particular fields of science, and help identify influential national experts and research groups. The tool will run on research data from various national and international sources, including Scopus Custom Data.

Sergey Salikhov, PhD, Director of the Department for the Development of Priority Directions of Science and Technology at the Ministry of Education and Science of the Russian Federation said, "With Russia's Map of Science we aim to build a tool which allows Russian scientists to create their own researcher profile, view colleague researchers' accounts and check facts and figures on article publications, patents and research funding sources. Currently we are building the infrastructure for the tool, maximizing the content of the database. For this our goal is to combine data from various sources, local as well as international. We are very pleased to have Scopus Custom Data secured for the project."

Igor Osipov, PhD, Regional Director for Russia and Belarus at Elsevier said, "The government's initiative to launch Russia's Map of Science will help reinforce growth and development of Russian academic research. We are honored to be able to contribute to the project by providing Scopus Custom Data, and by doing so help optimize nation-wide efforts in the strategic development of Russia's priority areas in science."

# # #

About Scopus

Scopus, the largest abstract and citation database of peer-reviewed literature, features smart tools to track, analyze and visualize scholarly research. Its vast database contains abstracts and references from 21,000 titles from more than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage in the fields of science, technology, medicine, social sciences and Arts & Humanities. Scopus was designed and developed with input from researchers and librarians internationally; and features direct links to subscribed full-text articles, other library resources and interoperability with applications such as reference management software.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact
Galina Yakshonak
Elsevier, Russia
+7-985-72-779-67
g.yakshonak@elsevier.com